Indonesia’s decision to enter an exclusive agreement of sharing H5N1 virus strains samples with Baxter International is controversial to say the least.
This move comes very soon after Jakarta announced that they will stop sharing information relating to the bird flu infections on the grounds of intellectual property protection. This, in my opinion, is a case of valuing money above lives.
While many are dying in Indonesia resulting from bird flu, its government could somehow overlook this fact and focus on making a quick buck through some “exclusive agreement”. How this deal helps Indonesia to protect this infectious property of theirs remains to be seen. This reeks of an opportunistic move that could go very wrong.
Baxter denies coaxing Indonesia to implement this move.